N/A
N=881
Efficacy of a Web-based Sexual Violence Risk Reduction Program for Female College Students
Sexual Violence
Bottom Line
View on ClinicalTrials.gov: NCT03726437 ↗Enrolled (actual)
881
Serious AEs
—
Results posted
Feb 2023
Primary outcome: Primary: Change From Baseline in Sexual Violence Victimization at 6-months Follow-up — 5.64; 5.68; 5.52; 8.15 score on a scale — p=.0002
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- RealConsent (Behavioral); Stress and Mood Management (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Georgia State University
- Primary completion
- Nov 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Sexual Violence Victimization at 6-months Follow-up |
5.64; 5.68; 5.52; 8.15; 3.69; 3.78 | .0002 sig |
| SECONDARY Change From Baseline in Alcohol Protective Behaviors at 6 Months |
53.53; 53.97; 56.8; 55.0 | .03 sig |
| SECONDARY Change From Baseline in Dating Risk Behaviors at 6-months Follow-up |
35.16; 35.08; 36.2; 36.1 | <.05 sig |
| SECONDARY Change From Baseline in "Number of Times Engaged in Binge Drinking" to 6-months |
1.71; 1.25; 1.11; 1.05 | .02 sig |
| SECONDARY Change From Baseline in "Average Number of Alcoholic Drinks Per Occasion in Last 30 Days" to 6-months |
1.64; 1.45; 1.4; 1.3 | .43 |
| SECONDARY Change From Baseline in Bystander Behavior at 6-months |
7.14; 6.58; 6.03; 7.6 | .006 sig |
Summary
This study evaluates the efficacy of a web-based program for female college freshmen ("RealConsent") in reducing their risk of sexual violence victimization. Half the participants will receive RealConsent-F and half will receive an attention-placebo control ("Stress and Mood Management").
Eligibility Criteria
Inclusion Criteria
- female, aged 18-20 years, full-time freshmen, matriculated at Georgia State University, Emory University, or University of Georgia, and single (i.e., not in a committed dating relationship).
Exclusion Criteria
- other education levels, married, and/or graduate status
Data sourced from ClinicalTrials.gov (NCT03726437). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.